Sol J. Barer, Director at NexImmune, Inc. (NEXI), bought 30,000 shares at $2.41 ($72K) on 2022-03-22, disclosed to the SEC on 2022-03-23.
Open-market purchase of $72k NEXI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-22 | $128K | — | Filing → |